29th Annual Conference on Drug & Medical Device Litigation

For 29 years, the American Conference Institute’s Drug and Medical Device Litigation Conference has brought together hundreds of product liability defense stakeholders from industry, private practice, and government to network, collaborate, and strategize on the current product liability landscape as well as to anticipate what is next on the horizon.

On December 4, Erin Bosman, chair of MoFo’s Complex Litigation + Advisement practice, will speak on the AI in Drug Development and Medical Devices: Unpacking Liability Risks in the Life Sciences panel at 11:00 a.m. ET. This panel will discuss the legal and regulatory landscape governing AI, consider recent guidance on AI/ML-Enabled Device Software Functions and the potential product liability risks, examine case law, and understand how companies can spot areas of potential product liability risk associated with the use of AI.

Erin will also speak on the “Get Us Out of This!”: Developing and Implementing an Exit Strategy to Conclude Drug and Device Litigation at 2:30 p.m. ET. The discussion will cover best practices for developing and implementing an effective exit strategy and common challenges faced in product liability settlements, conducting early assessment of risk and exposure, and deploying creative mediation and settlement strategies, among other topics.

For more information, please visit the conference website.